FKIE_CVE-2002-2446
Vulnerability from fkie_nvd - Published: 2015-08-04 14:59 - Updated: 2025-04-12 10:46
Severity ?
Summary
GE Healthcare Millennium MG, NC, and MyoSIGHT has a password of insite.genieacq for the insite account that cannot be changed without disabling product functionality for remote InSite support, which has unspecified impact and attack vectors.
References
Impacted products
| Vendor | Product | Version | |
|---|---|---|---|
| gehealthcare | millennium_mg_firmware | - | |
| gehealthcare | millennium_myosight_firmware | - | |
| gehealthcare | millennium_nc_firmware | - |
{
"configurations": [
{
"nodes": [
{
"cpeMatch": [
{
"criteria": "cpe:2.3:o:gehealthcare:millennium_mg_firmware:-:*:*:*:*:*:*:*",
"matchCriteriaId": "DD46362C-2338-4E63-8076-8E4A9FBC551F",
"vulnerable": true
},
{
"criteria": "cpe:2.3:o:gehealthcare:millennium_myosight_firmware:-:*:*:*:*:*:*:*",
"matchCriteriaId": "90FE8411-70AC-4C6B-9825-1015D04ADE27",
"vulnerable": true
},
{
"criteria": "cpe:2.3:o:gehealthcare:millennium_nc_firmware:-:*:*:*:*:*:*:*",
"matchCriteriaId": "C2286499-C442-4927-A070-19AD6D52314A",
"vulnerable": true
}
],
"negate": false,
"operator": "OR"
}
]
}
],
"cveTags": [],
"descriptions": [
{
"lang": "en",
"value": "GE Healthcare Millennium MG, NC, and MyoSIGHT has a password of insite.genieacq for the insite account that cannot be changed without disabling product functionality for remote InSite support, which has unspecified impact and attack vectors."
},
{
"lang": "es",
"value": "Vulnerabilidad en GE Healthcare Millennium MG, NC y MyoSIGHT, tiene una contrase\u00f1a insite.genieacq para la cuenta de insite que no se puede cambiar sin deshabilitar la funcionalidad del producto para el soporte remoto de InSite, lo cual tiene un impacto y vectores de ataque no especificados."
}
],
"id": "CVE-2002-2446",
"lastModified": "2025-04-12T10:46:40.837",
"metrics": {
"cvssMetricV2": [
{
"acInsufInfo": true,
"baseSeverity": "HIGH",
"cvssData": {
"accessComplexity": "LOW",
"accessVector": "NETWORK",
"authentication": "NONE",
"availabilityImpact": "COMPLETE",
"baseScore": 10.0,
"confidentialityImpact": "COMPLETE",
"integrityImpact": "COMPLETE",
"vectorString": "AV:N/AC:L/Au:N/C:C/I:C/A:C",
"version": "2.0"
},
"exploitabilityScore": 10.0,
"impactScore": 10.0,
"obtainAllPrivilege": false,
"obtainOtherPrivilege": false,
"obtainUserPrivilege": false,
"source": "nvd@nist.gov",
"type": "Primary",
"userInteractionRequired": false
}
]
},
"published": "2015-08-04T14:59:02.877",
"references": [
{
"source": "cve@mitre.org",
"url": "http://apps.gehealthcare.com/servlet/ClientServlet/2338955-100.pdf?REQ=RAA\u0026DIRECTION=2338955-100\u0026FILENAME=2338955-100.pdf\u0026FILEREV=1\u0026DOCREV_ORG=1"
},
{
"source": "cve@mitre.org",
"url": "http://apps.gehealthcare.com/servlet/ClientServlet/2354459-100.pdf?REQ=RAA\u0026DIRECTION=2354459-100\u0026FILENAME=2354459-100.pdf\u0026FILEREV=4\u0026DOCREV_ORG=4"
},
{
"source": "cve@mitre.org",
"url": "http://www.forbes.com/sites/thomasbrewster/2015/07/10/vulnerable-breasts/"
},
{
"source": "cve@mitre.org",
"url": "https://ics-cert.us-cert.gov/advisories/ICSMA-18-037-02"
},
{
"source": "cve@mitre.org",
"url": "https://twitter.com/digitalbond/status/619250429751222277"
},
{
"source": "af854a3a-2127-422b-91ae-364da2661108",
"url": "http://apps.gehealthcare.com/servlet/ClientServlet/2338955-100.pdf?REQ=RAA\u0026DIRECTION=2338955-100\u0026FILENAME=2338955-100.pdf\u0026FILEREV=1\u0026DOCREV_ORG=1"
},
{
"source": "af854a3a-2127-422b-91ae-364da2661108",
"url": "http://apps.gehealthcare.com/servlet/ClientServlet/2354459-100.pdf?REQ=RAA\u0026DIRECTION=2354459-100\u0026FILENAME=2354459-100.pdf\u0026FILEREV=4\u0026DOCREV_ORG=4"
},
{
"source": "af854a3a-2127-422b-91ae-364da2661108",
"url": "http://www.forbes.com/sites/thomasbrewster/2015/07/10/vulnerable-breasts/"
},
{
"source": "af854a3a-2127-422b-91ae-364da2661108",
"url": "https://ics-cert.us-cert.gov/advisories/ICSMA-18-037-02"
},
{
"source": "af854a3a-2127-422b-91ae-364da2661108",
"url": "https://twitter.com/digitalbond/status/619250429751222277"
}
],
"sourceIdentifier": "cve@mitre.org",
"vulnStatus": "Deferred",
"weaknesses": [
{
"description": [
{
"lang": "en",
"value": "CWE-255"
}
],
"source": "nvd@nist.gov",
"type": "Primary"
}
]
}
Loading…
Loading…
Sightings
| Author | Source | Type | Date |
|---|
Nomenclature
- Seen: The vulnerability was mentioned, discussed, or observed by the user.
- Confirmed: The vulnerability has been validated from an analyst's perspective.
- Published Proof of Concept: A public proof of concept is available for this vulnerability.
- Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
- Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
- Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
- Not confirmed: The user expressed doubt about the validity of the vulnerability.
- Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.
Loading…
Loading…